Orphan Drugs Sound Small but Can Lead to Big Drug Spending
High spending on prescription drugs with both orphan and non-orphan indications suggest potential misuse of Orphan Drug Act designations.
High spending on prescription drugs with both orphan and non-orphan indications suggest potential misuse of Orphan Drug Act designations.
Unlocking an Affordable Future: Key #3 Support and Equip Clinicians ENHANCE PATIENT OUTCOMES AND IMPROVE THE PATIENT EXPERIENCE At the core of the pharmacy benefit specialty function lies expertise used to ensure the right patient gets the right drug in
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. PBMS ARE REDUCING PRESCRIPTION DRUG COSTS FOR PATIENTS… We hope this
PCMA Launches New Campaign Aimed at Repealing the Medicare Prescription Drug Rebate Rule March 1, 2021 ARTICLE (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) unveiled a new campaign commending the Biden Administration for delaying the Medicare prescription drug
(Washington, D.C.) — The Pharmaceutical Supply and Payment Chain Coalition issued the following statement in response to the Administration’s 100-day review of the actions needed to address vulnerabilities in our nation’s pharmaceutical supply chain and what measures need to be taken in order
©2024 PCMA. All Rights Reserved.